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Checkpoint Rad proteins function early in the DNA damage check-
point signaling cascade to arrest cell cycle progression in response to
DNA damage. This checkpoint ensures the transmission of an intact
genetic complement to daughter cells. To learn about the damage
sensor function of the human checkpoint Rad proteins, we purified a
heteropentameric complex composed of hRad17-RFCp36-RFCp37-
RFCp38-RFCp40 (hRad17-RFC) and a heterotrimeric complex com-
posed of hRad9-hHus1-hRad1 (checkpoint 9-1-1 complex). hRad17-
RFC binds to DNA, with a preference for primed DNA and possesses
weak ATPase activity that is stimulated by primed DNA and single-
stranded DNA. hRad17-RFC forms a complex with the 9-1-1 hetero-
trimer reminiscent of the replication factor Cyproliferating cell nuclear
antigen clamp loaderysliding clamp complex of the replication ma-
chinery. These findings constitute biochemical support for models
regarding the roles of checkpoint Rads as damage sensors in the DNA
damage checkpoint response of human cells.
DNA damage in human cells activates several distinct bio-chemical pathways that may eliminate the damage (DNA
repair), arrest the cell cycle progression until the lesion is dealt
with (DNA damage checkpoint), or carry out programmed cell
death to eliminate seriously impaired cells (apoptosis). The
molecular mechanisms of repair and apoptosis are fairly well
understood; however, the DNA damage checkpoint response is,
at present, biochemically ill-defined.
The DNA damage checkpoint response is the set of biochemical
pathways that are activated by DNA damage to arrest cell cycle
progression as long as the damage persists (1). The response, as
revealed by genetic analyses in budding and fission yeasts, consists
of damage sensor, signal transducer, and effector components that
arrest the cell cycle at G1yS and G2yM (2–4). The signal transducers
and effectors are protein kinases that phosphorylate the target
molecules and halt cell cycle progression.
The least understood components of the checkpoint are the
DNA damage sensors. Genetic analyses in Schizosaccharomyces
pombe have identified six genes, Rad3, Rad17, Rad9, Rad1, Hus1,
and Rad26, that are collectively referred to as the checkpoint
Rad genes (5). These genes encode proteins thought to sense
DNA damage and activate the signal transduction checkpoint-
signaling cascade. The human homologs of the first five check-
point Rad proteins are ATMyATR, hRad17, hRad9, hRad1, and
hHus1. ATM and ATR belong to the phosphatidylinositol
3-kinase-related protein kinase family of proteins and are
thought to participate in both damage sensing and signal trans-
duction (6). The remaining four checkpoint Rad proteins are
thought to function primarily as damage sensors.
Recent in vivo biochemical studies in budding and fission yeasts
and in human cells, as well as computational analyses of these
proteins, have provided significant insights into possible mecha-
nisms of action for the damage sensor checkpoint proteins. The
Rad17 homologs exhibit sequence homology to all five subunits of
the replication factor C (RFC) (7–9), which functions as a clamp
loader. Evidence from budding and fission yeasts indicates that
Rad17 interacts with the four small subunits of RFC (10–12), and
thus, it has been proposed that Rad17 forms a complex with RFC
proteins in which the large subunit of RFC (p140) is replaced by
Rad17. Molecular modeling analyses of the rad checkpoint proteins
Rad9, Rad1, and Hus1 have suggested structural similarities among
these proteins and the sliding clamp, proliferating cell nuclear
antigen (PCNA) (13–15). These observations have led to the
proposal that these three rad proteins make a heterotrimeric
complex with a PCNA-like structure possessing similar yet distinct
functions as PCNA. In fact, immunoprecipitation and yeast two-
hybrid analyses have provided experimental support for a PCNA-
like Rad9-Hus1-Rad1 complex, termed the checkpoint 9-1-1 com-
plex (14, 16–21). Collectively, these findings have led to the
following model for the function of human checkpoint Rad proteins
(2, 15): The primary DNA lesions or the special structures arising
from processing these lesions by DNA repair or replication systems
are recognized by the Rad17-RFC complex, which then acts as a
molecular matchmaker (22) to recruit the checkpoint 9-1-1 complex
and loads it onto the DNA, thus initiating the DNA damage
checkpoint signaling. Although this is an attractive model, direct
biochemical evidence in support of the model is lacking.
In this study, we have purified and biochemically characterized
the hRad17-RFC and the checkpoint 9-1-1 complexes. Our results
show that the hRad17-RFCycheckpoint 9-1-1 pair exhibits similar-
ities to the RFCyPCNA pair in certain aspects but differs from the
latter in certain key reactions. We have demonstrated that, in vivo,
hRad17 forms a complex with the four RFC small subunits, and
that, in vitro, hRad17 competes with RFC p140 for the RFC small
subunits. Like p140, hRad17 depends on p38 for interaction with
the three core RFC subunits. hRad17-RFC, like the classical RFC,
binds to DNA, with a preference for primed DNA and possesses
weak ATPase activity that is stimulated by primed DNA templates
and single-stranded DNA. Unlike the classical RFC, hRad17-RFC
ATPase activity was not stimulated by PCNA. Although we were
unable to detect significant stimulation of hRad17-RFC ATPase
activity by the checkpoint 9-1-1 complex, we did detect a stable
interaction between the two complexes. This initial characterization
of the biochemical properties of the checkpoint Rads provides the
groundwork for future investigations regarding the roles of these
proteins as damage sensors in the DNA damage checkpoint.
Materials and Methods
Plasmids. hRad17 was amplified by PCR with pACT2-hRad17 [kind
gift of Jorge Vialard, Janssen Research Foundation, Beerse, Bel-
gium (9)] as the template. The PCR product was digested and
ligated into pcDNA4 (Invitrogen) to generate pcDNA4-
FlaghRad17 or ligated into pFastBacHTa (GIBCOyBRL) to gen-
erate pFast-His6-hRad17 and pFast-His6-Flag-hRad17. hRad9 was
amplified by PCR with pcDNA3-AU1-hRAD9 [kind gift of Larry
M. Karnitz, Mayo Foundation, Rochester, MN (18)] as a template,
and the PCR product was digested and ligated into pFastBac1 to
generate pFast-hRad9 and pFast-Flag-hRad9 that encode un-
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tagged and C-terminal Flag epitope-tagged hRad9, respectively.
hHus1 was amplified by PCR from a HeLa cDNA library and
cloned into pFastBac1 to generate pFast-hHus1 and pFast-Flag-
hHus1 that encode untagged and C-terminal Flag epitope-tagged
hHus1, respectively. hRad1 was amplified by PCR with pACT2-
hRad1A as a template [kind gift of J. Vialard (9)]. The PCR product
was digested and ligated into pFastBac1 to generate pFast-hRad1.
All plasmids were sequenced to verify that no mutations were
introduced during PCR and cloning.
Partial Purification of hRad17 from HeLa Cell-Free Extracts (CFE). CFE
from HeLa S3 cells were prepared as described (23). HeLa CFE
were initially fractionated by an analytical velocity sedimentation as
follows: 500 mg (100 ml) of HeLa CFE was applied to the top of a
12-ml gradient of 15–35% glycerol and centrifuged for 20 h at
37,000 rpm in a SW41 rotor (Beckman Instruments, Palo Alto, CA).
Twenty-four 0.5-ml fractions were collected from the bottom to top
and analyzed by SDSyPAGE and Western blotting (20 ml). The
sedimentation position of standard proteins was determined by a
gradient run in parallel.
For large-scale purification of hRad17, 1470 mg of HeLa CFE in
buffer D (25 mM Hepes-KOH, pH 7.9y0.1 M KCly12 mM MgCl2y
0.5 mM EDTAy2 mM DTTy16% glycerol [volyvol]) was loaded
onto a 330-ml DEAE Sepharose column, eluted with a 2 liter 0.1–1
M KCl gradient, and 50-ml fractions were collected. The fractions
were analyzed by Western blotting, and those containing hRad17
were pooled (eluting at 0.15 M KCl), resulting in a 7-fold purifi-
cation. The pooled fractions, containing 225 mg of protein, were
adjusted to 50 mM KCl, loaded onto a 300-ml SP Sepharose
column, and eluted with a 2-liter 0.05–1 M KCl gradient, and 40-ml
fractions were collected. The load and even fractions 16–52 (50 ml)
were analyzed by SDSyPAGE and Western blotting. This column
step resulted in a 12-fold purification of hRad17 (which peaked at
0.22 M KCl).
Expression and Purification of Recombinant Proteins. Human em-
bryonic kidney 293T cells were grown in DMEM (GIBCOy
BRL) supplemented with 10% FBS and 100 units of penicillin
and streptomycinyml. Cells (3 3 106) were transfected with 17
mg of pcDNA4-FlaghRad17 plasmid by using the calcium phos-
phate transfection method (24). Forty-eight hours after trans-
fection, cells were washed with PBS and lysed in 20 packed cell
volumes of lysis buffer [50 mM TriszHCl, pH 7.5y0.5% Nonidet
P-40yprotease inhibitors (Roche Molecular Biochemicals)] with
1 M NaCl. After a 15-min incubation on ice, the cell lysate
was centrifuged for 30 min at 32,000 3 g. The supernatant
was incubated with anti-Flag agarose for 4 h at 4°C. The resin was
then washed four times with lysis buffer and the protein was
eluted with elution buffer [50 mM Tris-Cl, pH 7.5y0.05%
Nonidet P-40yprotease inhibitorsy200 mgyml Flag peptide Sig-
ma)] with 1 M NaCl yielding '0.4 mg of protein.
Baculoviruses for expression of His6-hRad17, His6Flag-hRad17,
hRad9, Flag-hRad9, hHus1, Flag-hHus1, and hRad1 were gener-
ated with the BAC-TO-BAC baculovirus expression system
(GIBCOyBRL) and protocols suggested by the manufacturer.
Baculoviruses for expression of RFC p40, His6-p38, p37, and p36
were described (25). The optimal multiplicity of infection was
empirically determined for each recombinant virus. Expression of
more than one protein at a time was accomplished by the infection
of multiple viruses simultaneously (multiplicity of infection of five
for each). Monolayer High Five (HF) insect cells (Invitrogen),
grown in Grace’s insect medium (GIBCOyBRL) supplemented
with 10% FBS and 100 units of penicillin and streptomycinyml,
were infected with virus and then harvested after 48 h. The cells
were lysed and centrifuged as described above for 293T cells, with
the lysis buffer containing 0.3 M NaCl for the 9-1-1 complex and 1
M NaCl for the hRad17-RFC complex. The 9-1-1 complex was
purified directly with anti-Flag agarose as described above for 293T,
with the elution buffer containing 0.15 M NaCl. The hRad17-RFC
complex, which contains His6-Flag-tagged hRad17 and His6-tagged
p38, was first purified with Ni-NTA agarose (Qiagen, Chatsworth,
CA), and the protein was eluted with 50 mM TriszHCl (pH 7.5), 1
M NaCl, 0.5% Nonidet P-40, protease inhibitors, and 100 mM
imidazole. The eluate was then purified with anti-Flag agarose as
described above for 293T. The yield of 9-1-1 complex and hRad17-
RFC from 109 of cells was 3 and 5.6 mg, respectively.
Antibodies. hRad17 was detected with a rabbit polyclonal anti-
body raised against bacterially produced maltose-binding pro-
tein-tagged hRad17 (amino acids 1–170) and affinity-purified by
using bacterially produced glutathione S-transferase-tagged
hRad17 (amino acids 1–170) coupled to Pierce Amino Link resin
according to the manufacturer’s recommendations. The hRad1
rabbit polyclonal antibody was raised against a peptide corre-
sponding to amino acids 9–26, and the serum was used for
Western analysis. hRad9 was detected with affinity-purified
rabbit polyclonal antibody M-389 (Santa Cruz Biotechnology).
The anti-RFC p140 mAb was a kind gift of Bruce Stillman, Cold
Spring Harbor Laboratory, Plainview, NY (26). The anti-RFC
p37 polyclonal antibody has been described (27).
In Vitro Transcription-Translation of hRad17 and RFC Subunits. Cou-
pled in vitro transcription-translation reactions and immunoprecipi-
tations were performed as described (27). Briefly, template DNAs
(0.25 mg of each) that expressed hRad17 and the RFC subunits
were added to a 50-ml TNT Quick transcription-translation mix-
ture (Promega) containing 30 mCi (1 Ci 5 37 GBq) of 35S-labeled
methionine (1,175 Ciymmol, NEN) and incubated at 30°C for 90
min. In reactions that contained the RFC complex, 0.5 mg of pET
16a-p140 was used to compensate for low p140 expression. After
incubation, 50 units of DNaseI (Roche Molecular Biochemicals)
was added, and the mixture was incubated for 10 min at 30°C to
digest template DNAs. The labeled hRad17-RFC and RFC com-
plexes from a 20-ml aliquot of the reaction mixture were immuno-
precipitated as decribed (27). Ten percent of the reticulocyte lysate
(load) and 50% of the immunoprecipitated materials were sub-
jected to an SDSy12% PAGE, and labeled proteins were visualized
by autoradiography. To determine the stoichiometry of the subunits
in the hRad17-RFC complex, it was purified from reticulocyte
lysate (250 ml scale) by phosphocellulose chromatography and
sedimented twice in a 15–40% glycerol gradient as described
(25, 27). After separation by SDSyPAGE, the 35S-labeled proteins
in the peak glycerol gradient fraction were quantitated by using a
PhosphorImager.
DNA Binding and ATPase Assays. Nitrocellulose filter binding assays
were performed as described (28). ATPase reaction mixtures (10
ml) contained 25 mM TriszHCl (pH 7.5), 3 mM magnesium
acetate, 2 mM DTT, 200 mgyml BSA, 50 mM [g32P]ATP (4,400
cpmypmol), and DNA (type and amounts) as indicated. After 20
min at 37°C, aliquots (1 ml) were spotted on polyethyleneimine-
cellulose thin layer plates that were developed in 1.0 M formic
acid and 0.5 M LiCl at room temperature. 32Pi formation was
quantitated by PhosphorImager analysis.
Phosphatase Treatment of the 9-1-1 Complex. Three microliters ('1
mg) of purified C-Flag-hRad 9-1-1 complex was incubated with the
indicated amounts of l phosphatase (Stratagene) in the absence or
presence of 1 mM sodium orthovanadate at 30°C for 1 h.
Gel Filtration. Purified C-Flag-hRad9 9-1-1 complex (100 ml; '20
mg) was loaded onto a Superdex 200 10y30 column (Amersham
Pharmacia) and eluted with 50 mM TriszHCl (pH 7.5) and 300
mM NaCl. The column was run at 0.3 mlymin, and 0.5-ml
fractions were collected. Aliquots (100 ml) of the fractions were
resolved by 12.5% SDSyPAGE and visualized by silver staining.



























Purification of the Checkpoint Rad Complex. HF cells were infected
with baculoviruses expressing all eight subunits of the hRad17-
RFC and 9-1-1 complexes, including Flag-hRad9, and the check-
point complex was purified by affinity chomatography on anti-
Flag resin (yielding 3.8 mg from 106 cells) and analyzed by
SDSyPAGE and silver staining and Western blotting.
Results
Purification of the Rad17-RFC Complex. Currently, there is no in vitro
assay available to assess enzymatic activities associated with
either hRad17 or the hRad17-RFC complex. Therefore, we used
immunoblotting to follow these proteins during purification of
hRad17 from HeLa cells. Initially, we wanted to determine
whether hRad17 was present in multiple forms such as a
monomer or in association with the RFC small subunits. To this
end, we separated HeLa CFE by glycerol density centrifugation
and analyzed the fractions with antibodies against hRad17 and
RFC p37. Fig. 1A shows that there is a single peak for both
proteins. From this result, two conclusions can be made. First,
there is only one species of hRad17. Second, this species has
approximately the same molecular weight as RFC because the
RFC p37 subunit, which represents all of the complexes formed
with this and presumably the other RFC subunits, including
classical RFC, comigrates with hRad17. Thus these data are
consistent with the presence of a heteropentameric RFC com-
plex containing hRad17 instead of the large RFC p140 subunit,
as has been previously shown in yeast (10–12). This conclusion
is strengthened by the following findings made during our
attempts to purify hRad17 from HeLa cells.
Although immunoblots of HeLa CFE indicated that hRad17 is
a relatively abundant protein (quantified by using recombinant
hRad17 as the standard, data not shown), our repeated attempts to
purify a complex containing hRad17 by using conventional chro-
matography failed because after 3–4 chromatographic steps the
complex became unstable and the yield dropped drastically. How-
ever, these attempts revealed an interesting fact. As seen in Fig. 1B,
at the second chromatographic step hRad17 eluted as a single peak,
whereas p37, which represents all RFC-like complexes, eluted in
three peaks. Of these, peak III contains RFC p140 and thus
represents classical RFC; peak II contains hRad17 but no RFC
p140 and thus represents the hRad17-RFC complex; peak I con-
tains neither RFC p140 nor hRad17 and may represent other
complexes containing RFC p37 such as the recently identified
Ctf18-RFC complex (29, 30).
The purification profiles of hRad17 and the RFC subunits
suggest that hRad17 exists in a heteropentameric RFC complex.
We also obtained results from immunoprecipitation experiments
that further support the existence of a hRad17-RFC complex (data
not shown). In addition, we purified native hRad17 by affinity
chromatography by using an epitope-tagged protein. Human 293T
cells were transfected with a vector expressing the Flag-tagged
protein, and hRad17 was purified by immunoaffinity chromatog-
raphy. Fig. 1C (lane 1) shows that hRad17 purified in this manner
contains additional proteins in the size range of 36–40 kDa,
consistent with the size of RFC small subunits. Protein blotting
confirmed the identity of these proteins as RFC p36, p37, p38, and
p40 (data not shown). Thus, these findings show that hRad17 is
indeed in an RFC-like complex, and in combination with data in
Fig. 1A, the findings suggest that all of hRad17 is in this complex.
The hRad17-containing RFC complex may be referred to as the
checkpoint RFC to differentiate it from the classical RFC, which
may be more appropriately referred to as the replicative RFC.
However, to be more descriptive, the hRad17-containing complex
will simply be called hRad17-RFC.
Although the Flag-tagged hRad17 expressed in human cells
was useful in proving the existence of hRad17-RFC in these cells
under nearly physiological conditions, the amount and purity of
the protein purified by this method was insufficient for biochem-
ical characterization. To obtain large quantities of hRad17-RFC,
HF insect cells were coinfected with baculoviruses expressing
hRad17, and the four small RFC subunits and the complex was
purified by affinity chromatography with Ni-NTA agarose and
subsequent immunoaffinity chromatography. This method en-
abled us to purify milligram amounts of the complex of .95%
purity (Fig. 1C, lane 2). When necessary, hRad17-RFC was
further purified by size exclusion chromatography or glycerol
density gradient velocity sedimentation.
Order of Assembly of hRad17-RFC. The classical human RFC can be
reconstituted by expressing all five subunits in an in vitro transcrip-
tionytranslation system (27, 31) or in insect cells infected with
recombinant baculoviruses expressing the individual subunits (25,
32, 33). These reconstitution studies suggested a cooperative mech-
anism of assembly, whereby formation of a stable core complex of
p36, p37, and p40 is followed by cooperative binding of p38 and
p140 to the core complex (27). Although a complex of the four small
subunits has also been isolated (32, 33), its conversion to the
Fig. 1. Isolation of hRad17-RFC. (A) Glycerol gradient sedimentation of hRad17
present in crude HeLa extracts. HeLa CFE was subjected to glycerol gradient
centrifugation as described in Materials and Methods. Fractions were collected
from the bottom of the tube and analyzed by Western blotting with anti-hRad17
and anti-RFCp37 antibodies. The sedimentation position of reference proteins in
a parallel gradient is indicated. L, load. (B) Separation of at least three forms of
RFC. Fractions from the SP Sepharose column (see Materials and Methods) were
analyzed by Western blotting by using the indicated antibodies. The three RFC
complexesarerepresentedby I, II,andIII. (C)PurificationthehRad17-RFCcomplex
from transfected human 293T cells and baculovirus-infected insect HF cells. 293T
cells were transfected with pcDNA4-Flag-hRad17 and purified by using anti-Flag
agarose (lane 1). The hRad17-RFC complex was reconstituted in insect cells by
coinfectionwithfiverecombinantvirusescapableofexpressingHis6-Flag-hRad17
and each RFC small subunit (lane 2). The p38 subunit contains a His6 tag. The
complex was purified by chromatography with Ni-NTA and then anti-Flag aga-
rose as described in Materials and Methods. The proteins were visualized after
SDSyPAGE by silver staining. The amounts of protein loaded in lanes 1 and 2 were
1 and 0.5 mg, respectively.




















five-subunit holoenzyme upon addition of p140 is unclear. Thus, it
appears that p38 and p140 require each other for interaction with
the core complex. We wanted to know whether hRad17-RFC was
assembled by the same route with hRad17 replacing p140. The five
RFC proteins and hRad17 were expressed in an in vitro transcrip-
tionytranslation system containing the genes in various combina-
tions, and the complexes were immunoprecipitated with anti-p37
antibodies and analyzed by autoradiography. As apparent in Fig. 2,
in this system both RFC and hRad17-RFC form efficiently (lanes
6 and 9), and when both p140 and hRad17 are present in the same
mixture, they compete for assembly with the core complex (com-
pare the p140 intensities in lanes 3 and 9). Importantly, p38 appears
to be necessary for the association of hRad17 with the core
p36-p37-p40 complex to form hRad17-RFC. Thus, we conclude
that hRad17 behaves like p140 with regard to its interactions with
the other RFC subunits. Along these lines the hRad17-RFC
complex contains all five subunits in a one-to-one stoichiometry.
When the in vitro translation products of a mixture of hRad17, RFC
p36, p37, p38, and p40 were purified through phosphocellulose and
then sedimented in a 15–40% glycerol gradient, the hRad17-RFC
complex migrated at the same position as the classic RFC complex.
Quantification of the 35S-labeled proteins in the peak fraction by
PhosphorImaging gave the following ratios: 1 (hRad17):1.09,
(p40):1.37, (p38):1.32, (p37):1.24 (p36).
ATPase Activity of hRad17-RFC. The classical RFC is an ATPase of
moderate strength whose activity is stimulated by DNA and
PCNA (33–36). Although the three-subunit RFC core complex
exhibits weak ATPase activity that is modestly stimulated by
DNA, the holoenzyme is more strongly stimulated by both DNA
and PCNA (32, 34–37). We wanted to know whether hRad17-
RFC had similar properties. The five-subunit hRad17-RFC and
the three-subunit core complex were made in insect cells,
isolated by affinity chromatography, and then further purified by
glycerol density gradient sedimentation. The fractions were
analyzed by SDSyPAGE and Coomassie blue staining (Fig. 3 A
and B) and tested for ATPase activity (Fig. 3C). Densitometric
analysis of the bands in the hRad17-RFC peak fractions showed
that hRad17-RFC has a stoichiometry of 1.17 (hRad17):1.34
(p40 1 p38):1 (p36 1 p37) that along with the sedimentation
data are consistent with a monomeric structure of the hetero-
pentamer. Importantly, the peak fractions of hRad17-RFC
contain more ATPase activity than the peak fractions of the core
complex (Fig. 3C). More detailed analysis of the hRad17-RFC
ATPase activity is summarized in Table 1. As is apparent,
hRad17-RFC behaves similarly to the RFC holoenzyme: It is
more active than the three-subunit core and is strongly stimu-
lated by single-stranded DNA but not double-stranded (ds)
DNA, although the level of stimulation is approximately one-half
of that seen with RFC. Of importance, in contrast to RFC,
hRad17-RFC ATPase is not stimulated by PCNA (data not
shown). Of equal interest, the checkpoint 9-1-1 complex, which
in current models is considered to be the PCNA counterpart of
the checkpoint clamp loaderysliding clamp pair, also had little
effect on hRad17-RFC in the presence or absence of DNAs used
in Table 1. Whether this is a real difference between the two
types of complexes (RFCyPCNA vs. hRad17-RFCy9-1-1 com-
plex) or indicative of a unique DNA structure that might be
necessary to observe the stimulatory effect of the checkpoint
9-1-1 complex on hRad17-RFC ATPase activity remains to be
seen. It is clear, however, that hRad17-RFC is an RFC-like
ATPase and its activity is stimulated by DNA.
Fig. 2. Order of assembly of hRad17-RFC. An in vitro transcriptionytranslation
system containing the indicated expression vectors was used to radiolabel the
corresponding proteins. The products were immunoprecipitated with anti-p37
antibodies, separated on SDSyPAGE, and analyzed by autoradiography. L, load;
Pre, preimmune serum, and I, immune (anti-p37) serum.
Fig. 3. The copurification of ATPase activity with hRad17-RFC. (A and B)
Analysis of glycerol gradient fractions of hRad17-RFC and p36-p37-p40 core
RFC by SDSyPAGE and Coomassie blue staining. hRad17-RFC (0.2 ml, 0.73
mgyml) or the p36-p37-p40 core RFC complex (0.2 ml, 1 mgyml) was loaded
onto a 5-ml 15–35% glycerol gradient and centrifuged for 20 h at 4° at
250,000 3 g. Fractions were collected from the bottom of the gradients and
10 ml of each was loaded onto the gels. (C) ATPase activity of hRad17-RFC and
core RFC. Each fraction (1 ml) was analyzed for ATPase activity in the presence
of 12.5 mM (as nucleotides) poly dA4000:oligo dT12–18 as indicated in Materials
and Methods. Peak fractions, fraction 10 for hRad17-RFC and fraction 16 for
core RFC, contained 25 and 59 ng of proteinyml, respectively.
Table 1. Comparison of ATPase activities of RFC, hRad17-RFC,
and the 3-subunit complex
DNA added RFC hRad17-RFC 3S
None 5.6 6.0 1.0
Poly dA4000:Oligo dT12–18 24.1 15.2 2.5
fXssDNA 64.9 28.8 13.0
fXRFI 5.7 6.3 1.1
Reactions were carried out as described in Materials and Methods in the
presence or absence of 25 mM of the indicated DNA. The values indicate pmol
Piymin per pmol of complex. The 3-subunit complex (3S) is composed of p40,
p37, and p36.



























DNA Binding of hRad17-RFC. RFC binds to DNA with preference for
primer-template-like structures (34). We tested hRad17-RFC for
similar properties. As seen in Fig. 4, both RFC and hRad17-RFC
have comparable affinities for single- and dsDNAs, and both
protein complexes bind preferentially to primed DNA consistent
with a role of a clamp loader at a primer terminus or a similar type
structure.
Purification of the Checkpoint 9-1-1 Complex. To isolate the hRad9-
hHus1-hRad1 complex, we coinfected HF insect cells with bacu-
loviruses expressing each of the subunits with either a Flag tag on
the C terminus of hRad9 or hHus1. Immunoaffinity purification
yielded the heterotrimeric complex with the three subunits, hRad9,
hHus1, and hRad1, in a 1:1.2:1.2 stoichiometry as determined by
densitometric scanning of a Coomassie blue-stained gel (Fig. 5A).
Immunoblots of hRad9 from human cell extracts reveal multiple
species ranging in size from 55 to 70 kDa, although hRad9 has a
theoretical Mr of 45 kDa, and the fraction of heavily phosphorylated
forms increase upon DNA damage (18, 38). It has been reported
that only the phosphorylated forms of hRad9 associate with hRad1
and hHus1 as determined by coimmunoprecipitation experiments
(18, 21). Therefore, it was of interest to determine the effect of
phosphorylation on complex formation with recombinant proteins.
As is apparent in Fig. 5A, hRad9 made in baculovirus-infected cells
is mainly in the form of two species, which based on apparent
molecular weights represent different levels of phosphorylation in
insect cells. The stoichiometry of the subunits, and the elution
pattern from gel exclusion chromatography (Fig. 5C), indicates that
both of the forms of hRad9 are in a complex with hRad1 and
hHus1. To investigate the role of phosphorylation in complex
stability, checkpoint 9-1-1 was treated with l phosphatase and
analyzed by gel exclusion chromatography. Fig. 5B shows that with
increasing concentrations of l phosphatase there is a gradual
conversion of hRad9 to the nonphosphorylated form, and inter-
estingly during this conversion, discreet intermediate species are
detected. When the maximally dephosphorylated form of hRad9
was analyzed by gel exclusion chromatography, the majority of the
proteins migrated identically to the untreated 9-1-1 complex (Fig.
5 C and D). These results suggest that hyperphosphorylation of
hRad9 is not required for the 9-1-1 complex stability. Whether or
not any phosphorylation is required for the formation of the
complex remains to be investigated.
Formation of the Checkpoint Rad Complex. It is hypothesized that
hRad17-RFC and the 9-1-1 complex function in a manner analo-
gous to the conventional RFCyPCNA pair (3, 15). Complex for-
mation between RFC and PCNA on and off DNA has been well
documented (34); there is, however, no direct experimental evi-
dence for a similar complex between hRad17-RFC and the check-
point 9-1-1 complex. To find out whether such a complex exists, we
infected HF insect cells with baculoviruses expressing the eight
subunits of both complexes with the hRad9 containing a Flag tag.
As a control, all of the subunits except hRad9 were expressed. The
cell lysates were mixed with the anti-Flag resin and the bound
material was analyzed by protein blotting for selected subunits of
both complexes. As seen in Fig. 6, the hRad17-RFC is bound to the
9-1-1 complex. Similar results were obtained by mixing the sepa-
rately purified hRad17-RFC and 9-1-1 complexes and analyzing the
mixture by glycerol density gradient sedimentation (data not
shown). Thus, hRad17-RFC and the 9-1-1 complex do form a
RFCyPCNA-like complex with a special role in the DNA damage
checkpoint. We propose the name checkpoint Rad complex to
indicate its composition and unique function.
In the RFCyPCNA pair, RFC binds to the primer terminus,
recruits PCNA to the site, and opens the PCNA ring to clamp it
onto DNA, thus providing the processivity factor for DNA poly-
merases d and « (see ref. 34). A standard assay for the molecular
matchmaking activity of RFC is to measure RFC-dependent bind-
ing of PCNA to DNA; a nicked DNA circle is mixed with RFC and
PCNA in the presence ATP, and then the free protein and DNA
are separated by gel exclusion chromatography. Under these con-
Fig. 4. DNA-binding activity of hRad17-RFC. The indicated amounts of RFC or
hRad17-RFC were incubated in a reaction mixture (30 ml) containing either 40
fmol of 32P-labeled 50-nt single-stranded (ss), 50-bp dsDNA or a primed 50-bp
dsDNA with a 50-nt ssDNA (59 overhang) in 25 mM Hepes (pH 7.5), 175 mM NaCl,
3mMMgCl2,1mMDTT,and0.1mgymlBSAfor30minon ice.ThefractionofDNA
bound to the protein was quantitated by a nitrocellulose filter-binding assay. The
details of the DNA substrates used were described (28).
Fig. 5. Purification and characterization of the checkpoint 9-1-1 complex. (A)
Purification of the 9-1-1 complex. HF insect cells were infected with baculoviruses
expressing all three subunits with tags where indicated, and the complex was
purified by immunoaffinity chromatography as described in Materials and Meth-
ods. Lane 1, complex purified through the Flag tag on hRad9 (0.4 mg loaded) and
lane 2, complex purified through the Flag tag on hHus1 (0.4 mg loaded). (B) Effect
of l phosphatase on the 9-1-1 complex. The complex was treated with 0, 3.2, 16,
80, and 80 units of phosphatase in lanes 1–5, respectively, under conditions
described by the manufacturer. After 1-h incubation at 30°C, the products were
analyzed by SDSyPAGE and silver staining. (C and D) Dephosphorylated hRad9
remains in the 9-1-1 complex. Checkpoint 9-1-1 complexes, before (C) or after (D)
lphosphatasetreatment,wereseparatedbygelfiltration,andthefractionswere
analyzed by SDSyPAGE and silver staining.




















ditions, PCNA is found associated with the nicked DNA circle only
in the presence of RFC and ATP (39). Current models predict a
similar function for the checkpoint Rad complex. However, in
repeated attempts with this experimental design, we were unable to
detect the loading of the checkpoint 9-1-1 complex onto DNA by
RFC or hRad17-RFC (data not shown). It is possible that different
DNA structures, further posttranslational modifications of the
checkpoint Rad complex, or additional factors are needed for
loading of the checkpoint sliding clamp onto DNA.
Discussion
Recent computational and experimental studies have indicated that
the human checkpoint Rad proteins make RFC-like and PCNA-
like complexes with the distinct property of recognizing either
primary or secondary DNA lesions and thereby initiating the DNA
damage checkpoint cascade (3, 13). To learn about these proposed
complexes and the features that differentiate them from the
classical RFC and PCNA, we purified both hRad17-RFC, which is
proposed to function as a clamp loader, and also the checkpoint
9-1-1 complex, which is predicted to be a checkpoint sliding clamp.
The purified hRad17-RFC has the predicted subunit compo-
sition of hRad17-RFCp36-RFCp37-RFCp38-RFCp40. Fraction-
ation of CFE shows that virtually all of hRad17 exists in this
complex. This finding contrasts with a report claiming that the
majority of hRad17 is in the nucleolus and migrates out into the
nucleoplasm to associate with other partners only upon DNA
damage (40). Further studies are needed to understand the
source of this discrepancy. In other aspects, hRad17-RFC ex-
hibits the predicted RFC-like properties: It is a DNA-stimulated
ATPase with a preference for primed DNA. In contrast with
RFC, however, it does not associate with PCNA but instead
specifically binds to the 9-1-1 complex.
The purified 9-1-1 complex also exhibited some of the pre-
dicted properties in terms of one-to-one stoichiometry of the
three subunits and its specific interaction with hRad17-RFC but
not with the classical RFC. We were unable to load the 9-1-1
complex onto primed DNA by either hRad17-RFC or RFC, and
thus the checkpoint sliding complex function of the 9-1-1 com-
plex remains to be demonstrated. There might be several reasons
for our failure to load the 9-1-1 complex onto nicked DNA.
Conceivably, more specialized DNA structures may be needed
for loading the 9-1-1 complex. Exonuclease activity has been
detected in both the hRad1 (41) and the hRad9 (42) subunits. It
is possible that under appropriate conditions these nuclease
activities aid in the loading process. The 9-1-1 complex itself has
a weak nuclease activity (data not shown) that needs further
characterization. Alternatively, it is possible that either post-
translational modification of the checkpoint Rad complex or its
association with some yet to be identified accessory factors is
necessary for the loading of the checkpoint sliding clamp.
Indeed, it has been found that the Hus1 protein of S. pombe (16)
and the hRad9 (18, 38) and hRad17 (43) are phosphorylated by
the ATMyATR family of kinases upon DNA damage. Further-
more, it has been reported that phosphorylation of hRad17 by
ATR is required for high affinity interaction with hRad1, and
presumably the entire 9-1-1 complex (43). Although in our in
vitro system, we do detect a strong hRad17-RFCy9-1-1 complex
interaction in the absence of ATR-induced hRad17 phosphor-
ylation, it is possible that this interaction is stronger or qualita-
tively different with the ATRyATM-phosphorylated hRad17,
enabling the hRad17-RFC to function as a clamp loader of the
9-1-1 complex and activate the checkpoint-signaling cascade.
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Fig. 6. Isolation of the checkpoint Rad complex. HF cells infected with either
all of the subunits of the hRad17-RFC and 9-1-1 complexes, including Flag-
tagged hRad9, or all of the subunits except hRad9 were lysed, and the complex
was purified by immunoaffinity chromatography and analyzed by Western
blotting as described in Materials and Methods.
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